In T2DM patients, immune T cells exhibit a pronounced inflammatory phenotype, with a significant predominance of CD4+ T cells secreting Interferon-γ (IFN-γ) compared to control subjects, indicating heightened inflammatory activity of CD4+ T cells in T2DM [36]. The gene discussed is IFNG; the disease is type 2 diabetes mellitus.